SCHEMBL8102528

SCHEMBL8102528

CC=CCC1=C(NC(=O)CCCC)C(=O)c2cc(O)c(O)cc21

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.41
CA1 P00915 2/20 0.41
CA2 P00918 2/20 0.41
CYP1A2 P05177 2/20 0.41
CYP2C9 P11712 2/20 0.41
CYP2C19 P33261 2/20 0.41
CYP2D6 P10635 1/20 0.41
CA12 O43570 1/20 0.41
CA9 Q16790 1/20 0.41
KDM4E B2RXH2 2/20 0.39
HPGD P15428 2/20 0.39
ALOX12 P18054 1/20 0.39
TDP2 O95551 1/20 0.38
PAX8 Q06710 1/20 0.38
HKDC1 Q2TB90 1/20 0.38
TLR9 Q9NR96 1/20 0.38
IAPP P10997 1/20 0.36
PSMB11 A5LHX3 2/20 0.36
PSMA7 O14818 2/20 0.36
PSMB1 P20618 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8102740 0.87 GAA (0.40) ALDH1A1CYP1A2CYP2C19HPGDCNR1
SCHEMBL8100852 0.85 ALDH1A1 (0.46) ALDH1A1CA1CA2CYP1A2CYP2C9
SCHEMBL8102148 0.85 TDP2 (0.52) ALDH1A1CA1CA2CA12CA9
SCHEMBL8100403 0.84 ALDH1A1 (0.45) ALDH1A1CA1CA2CYP1A2CYP2C9
SCHEMBL8100293 0.84 ALDH1A1 (0.45) ALDH1A1CA1CA2CYP1A2CYP2C9
SCHEMBL8102584 0.83 ALDH1A1 (0.44) ALDH1A1CA1CA2CYP1A2CYP2C9
SCHEMBL8101873 0.82 ALDH1A1 (0.43) ALDH1A1CA1CA2CYP1A2CYP2C9
SCHEMBL8092894 0.81 ALDH1A1 (0.47) ALDH1A1CA1CA2CYP1A2CYP2C9
SCHEMBL8102968 0.81 ALDH1A1 (0.42) ALDH1A1CA1CA2CYP1A2CYP2C9
SCHEMBL8103085 0.81 KDM4E (0.42) ALDH1A1CA1CA2CYP1A2CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6013674-A INDENONE AMIDE DERIVATIVES, USEFUL FOR FOR THE INHIBITION OF LEUKOCYTE ADHERENCE TO ENDOTHELIAL CELLS; USEFUL IN THE TREATMENT OF INFLAMMATORY DISEASES, AS ARTHRITIS, ASTHAMA, PSORIASIS, RESPIRATORY DISTRESS SYNDROME, STROKE AND ULCER ELI LILLY AND COMPANY (US) 2000-01-11 US disclosed
EP-0882706-A1 Cell adhesion inhibitors ELI LILLY AND COMPANY (US) 1998-12-09 EP disclosed